المؤلفون: Urrego Novoa, José Ricardo

المساهمون: Hincapié Echeverry, Ana Lucia, Díaz Rojas, Jorge Augusto, Farmacogenética del Cáncer

مصطلحات موضوعية: 610 - Medicina y salud::616 - Enfermedades, 330 - Economía::336 - Finanzas públicas, 610 - Medicina y salud::615 - Farmacología y terapéutica, Costos de la Atención en Salud, Neoplasias de la Mama, Modelos Organizacionales, Organizaciones del Seguro de Salud, Health Care Costs, Breast Neoplasms, Models, Organizational, Preferred Provider Organizations, Economía de la salud y organizaciones, Costos y análisis de costos, Costos de atención médica, Costos directos del servicio, Neoplasias, Neoplasias por sitio, Health economics and organizations, Costs and cost analysis, Direct service costs, Neoplasms, Neoplasms per site

جغرافية الموضوع: Colombia

وصف الملف: xxii, 215 páginas; application/pdf

Relation: Majeed W, Aslam B, Javed I, Khaliq T, Muhammad F, Ali A, et al. MINI-REVIEW Breast Cancer : Major Risk Factors and Recent Developments in Treatment. 2014;15:3353–8.; Yin W, Wang J, Jiang L, James Kang Y. Cancer and stem cells. Vol. 246, Experimental Biology and Medicine. SAGE Publications Inc.; 2021. p. 1791–801.; Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease 2021: Findings from the GBD 2021 Study. Seattle, WA; 2024; Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends — An Update. 2016;25(January):16–28.; Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018;68(6):394–424. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30207593; Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;(February):1–35.; De, Fondo Colombiano de Enfermedades de Alto Costo C de AC (CAC). Situación del cáncer en la población adulta atendida en el SGSSS de Colombia 2022. Bogotá D.C.; 2023.; Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2006–14.; Drummond M. SM ,Claxto. C ,Stoddar. g. ,Torranc. G. Methods for the Economic Evaluation of Health Care Programmes. Fourth. New York: Oxford University Press; 2015.; Jo C. Cost-of-illness studies : concepts , scopes , and methods. 2014;327–37.; Lipscomb J, Yabroff KR, Brown ML, Lawrence W, Barnett PG. Health Care Costing: Data, Methods, Current Applications. Med Care [Internet]. 2009;47(7_Supplement_1):S120–6. Available from: http://journals.lww.com/lww-medicalcare/Fulltext/2009/07001/Health_Care_Costing__Data,_Methods,_Current.1.aspx %5Cnhttp://journals.lww.com/lww-medicalcare/Fulltext/2009/07001/Inventory_of_Data_Sources_for_Estimating_Health.21.aspx %5Cnhttp://journals.lww.; Gallardo-Solarte K. K, Benavides-Acosta F.P. FP, Rosales-Jiménez R. R. Costos de la enfermedad crónica no transmisible: la realidad colombiana. Ciencias la Salud [Internet]. 2016;14(1):103–14. Available from: http://revistas.urosario.edu.co/index.php/revsalud/article/view/4596; Barlow WE. Overview of methods to estimate the medical costs of cancer. Med Care. 2009;July(47(7 Suppl 1)):S33–S36.; Gamboa Ó, Buitrago LA, Lozano T, Dieleman S, Gamboa C, Guzmán ÉL, et al. Costos directos de la atención del cáncer de mama en Colombia. Rev Colomb Cancerol [Internet]. 2016;20(2):52–60. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0123901516300014; Arredondo A, Damián T. Costos economicos en la produccion de servicios de salud: Del costo de los insumos al costo de manejo de caso. Salud Publica Mex. 1997;39(2):117–24; Cerda L J. Glosario de términos utilizados en evaluación económica de la salud. Rev Med Chil [Internet]. 2010;138(Supl 2):76–8. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010001000003&lng=es&nrm=iso&tlng=es; Ripari Nadia MNEM. Costos de enfermedades: una revisión crítica de las metodologías de estimación. Lect Econ [Internet]. 2012;(77):253–82. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-25962012000200008&lang=pt; Instituto de Evaluación Tecnológica en Salud - IETS. Manual metodológico para la elaboración de análisis de impacto presupuestal de tecnologías en salud en Colombia. Bogota D.C.; 2023.; Ministerio de salud y protección [Internet]. Manual Tarifario SOAT 2024 [Internet]. 2024. p. 4–6. Available from: https://consultorsalud.com/manual-tarifario-soat-2024-version-pdf/; Aminuddin F, Bahari MS, Zainuddin NA, Hanafiah ANM, Hassan NZAM. The Direct and Indirect Costs of Cancer among the Lower-Income Group: Estimates from a Pilot and Feasibility Study. Asian Pacific J Cancer Prev. 2023;24(2):489–96.; Xia Y, Chen Y, Chen J, Gan Y, Su C, Zhang H, et al. Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status? Front Public Heal. 2023;11; Mohammadpour S, Soleimanpour S, Javan-Noughabi J, Gallehzan NA, Aboutorabi A, Jahangiri R, et al. A systemmatic literature review on indirect costs of women with breast cancer. Vol. 20, Cost Effectiveness and Resource Allocation. BioMed Central Ltd; 2022.; Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, et al. Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001–2030. Scand J Public Health. 2019 Jul 1;47(5):482–91.; Bugge C, Sæther EM, Brustugun OT, Kristiansen IS. Societal cost of cancer in Norway –Results of taking a broader cost perspective. Health Policy (New York). 2021 Aug 1;125(8):1100–7.; Palacios A, Rojas-Roque C, González L, Bardach A, Ciapponi A, Peckaitis C, et al. Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review. Vol. 39, PharmacoEconomics. Adis; 2021. p. 485–502.; Gianino MM, Lenzi J, Bonaudo M, Fantini MP, Siliquini R. Organized screening programmes for breast and cervical cancer in 17 EU countries : trajectories of attendance rates. 2018;1–13.; Guy GP, Yabroff KR, Ekwueme DU, Rim SH, Li R, Richardson LC. Economic burden of chronic conditions among survivors of cancer in the United States. J Clin Oncol. 2017;35(18):2053–61.; Vazin A, Karimzadeh I, Karamikhah R, Oveisi Z, Mohseni S, Keykhaee M, et al. Clinical and economical impacts of guideline implementation by the pharmaceutical care unit for high cost medications in a referral teaching hospital. BMC Health Serv Res. 2018;18(1):1–10.; Diaz JA, Urrego-Novoa JR, Moreno JA, Huerfano C, Prieto VA. Analisis de Costo-Efectividad de Anidulafungina en el Tratamiento de la Candidiasis Invasiva en Colombia. Value Heal. 2015;18(7):A870.; Špacírová Z, Epstein D, García-Mochón L, Rovira J, Olry de Labry Lima A, Espín J. A general framework for classifying costing methods for economic evaluation of health care. Eur J Heal Econ. 2020 Jun 1;21(4):529–42.; Mihalopoulos C, Le LKD, Chatterton M Lou, Bucholc J, Holt-Lunstad J, Lim MH, et al. The economic costs of loneliness: a review of cost-of-illness and economic evaluation studies. Vol. 55, Social Psychiatry and Psychiatric Epidemiology. Springer; 2020. p. 823–36.; Wu J, Liu H, Hu T, Long M, Zhou X, Wang S. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database. Ann Transl Med. 2022 Mar;10(6):365–365.; Franklin M, Pollard D, Sah J, Rayner A, Sun Y, Dube F, et al. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review. Vol. 41, Advances in Therapy. Adis; 2024. p. 2700–22.; Ibarrondo O, Lizeaga G, Martínez-Llorente JM, Larrañaga I, Soto-Gordoa M, Álvarez-López I. Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component. Gac Sanit. 2022 May 1;36(3):246–52.; Omer AAA, Bin Dayel SA, Hummedi ASA, Almuhaimed NIA. The epidemiological and clinicopathological features of breast cancer in Riyadh, Saudi Arabia. Saudi Med J. 2024;45(3):288–94; Rivero Cuadrado A. Guía Pedagógica para la Implementación de los sistemas de clasificación de pacientes (Grd) en instituciones prestadoras de servicios de salud (Ips). Bogotá D.C.; 2012.; Gorbanev I, Cortés Martínez AE, Agudelo Londoño S, Yepes Lujan FJ. Grupos relacionados por el diagnóstico: experiencia en tres hospitales de alta complejidad en Colombia. Univ Médica [Internet]. 2016;57(2):171–81. Available from: http://revistas.javeriana.edu.co/index.php/vnimedica/article/view/17031; Duque MI, Fernando Gómez R-L, Albeiro M-J, Agudelo O, Isabel M, Roldán D, et al. Análisis De Los Sistemas De Costos Utilizados En Las Entidades Del Sector Salud En Colombia Y Su Utilidad Para La Toma De Decisiones. Rev del Inst Int Costos. 2009;525.; Wilkinson AN, Seely JM, Rushton M, Williams P, Cordeiro E, Allard-Coutu A, et al. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing. Curr Oncol. 2023 Sep 1;30(9):7860–73.; Institute for Quality and Efficiency in Health Care (IQWiG). General Methods - Version 6.1 [Internet]. Germany; 2022 Jan [cited 2024 Oct 12]. Available from: https://www.ispor.org/heor-resources/more-heor-resources/pharmacoeconomic-guidelines/pe-guideline-detail/germany; Chicaiza Becerra L, García Molina M, Oviedo S, Urrego J, Rincón C RA y GP. Costo efectividad del suplemento de calcio para reducir la mortalidad materna asociada a la preeclampsia. Bogotá D.C.; 2015. (Documentos FCE-CID). Report No.: 34; Haji-Sheikhi F, Fragala MS, Bare LA, Rowland CM, Goldberg SE. Prediction of Future Medical Costs by Modifiable Measures of Health. Clin Outcomes Res. 2023;15:525–34.; Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018. Pharmacoeconomics. 2020 Oct 1;38(10):1135–45.; Marques ICP, Alves MC. Hospital Costing Methods: Four Decades of Literature Review. J Risk Financ Manag. 2023 Oct 1;16(10).; Ministerio de Salud y Protección Social; Instituto de Evaluación Tecnológica en Salud; Instituto Nacional de Cancerología. Guía De Práctica Clínica para la detección temprana, tratamiento integral, seguimiento y rahabilitación del cáncer de mama. Guía para profesionales de la salud [Internet]. Bogotá D.C.; 2017. Available from: http://imss.gob.mx/profesionales-salud/gpc; Faria R MA. Documentos técnicos de apoyo a la construcción del caso de referencia colombiano para la evaluación económica en salud. Bogotá DC: Instituto de Evaluación Tecnológica - IETS [Internet]. Bogotá D.C.; 2014. Available from: http://www.iets.org.co/Manuales/Manuales/Documentos-tecnicos-espanol.pdf; Xu X, Nardini HKG, Ruger JP. Micro-costing studies in the health and medical literature: Protocol for a systematic review. Syst Rev. 2014;3(1):1–7; Tan SS, Bouwmans CAM, Rutten FFH, Hakkaart-Van Roijen L. Update of the dutch manual for costing in economic evaluations. Int J Technol Assess Health Care. 2012;28(2):152–8.; Bergmo TS. How to measure costs and benefits of ehealth interventions: An overview of methods and frameworks. J Med Internet Res. 2015;17(11).; Guerrero-c R, Parody G, Fe S, Osorio DI. Guía Metodológica Realización de Evaluaciones Económicas en el marco de Guías de Práctica Clínica - Versión final completa. 2014; Parada-vargas LA, Taborda-restrepo A. Modelos de evaluación económica: sua aplicación en las decisiones sanitaria. Rev Colomb Psiiquiat. 2011;40(2):352–62; Samuelson P NW. Economía. 18th ed. Madrid, España: Mc Graw Hill/Interamericana de España; 2006. 122–38 p.; Ripari NEMMN. Costos de enfermedades : clasificación y perspectivas de análisis. Rev Cienc Salud. 2017;15(1):49–58.; Hutton G, Baltussen R. Cost valuation in resource-poor settings. Health Policy Plan. 2005;20(4):252–9.; Margier J, Baffert S, Le Corroller-Soriano AG, Baffert S, Bertaux AC, Bonastre J, et al. Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies? Rev Epidemiol Sante Publique. 2018;66:S93–9.; Lipscomb J, Barnett PG, Brown ML, Lawrence WF, Yabroff KR, Lund JL, et al. Health Care Costing: Data, Methods, Current Applications. Med Care [Internet]. 2009;47(7_Supplement_1):S120–S126. Available from: http://journals.lww.com/lww-medicalcare/Fulltext/2009/07001/Health_Care_Costing__Data,_Methods,_Current.1.aspx; Wijeysundera HC, Wang X, Tomlinson G, Ko DT, Krahn MD. Techniques for estimating health care costs with censored data: An overview for the health services researcher. Vol. 4, ClinicoEconomics and Outcomes Research. Dove Medical Press Ltd; 2012. p. 145–55; Brown, ML; Riley, GF; Schussler, N; Etzioni R. Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data. Med Care. 2002;40(8, Supplement):104–17; Yabroff KR, Warren JL, Schrag D, Mariotto A, Meekins A, Topor M, et al. Comparison of Approaches for Estimating Incidence Costs of Care for Colorectal Cancer Patients. Med Care [Internet]. 2009;47(Supplement):S56–63. Available from: http://insights.ovid.com/crossref?an=00005650-200907001-00010; Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100(9):630–41.; Mariotto AB, Enewold L, Zhao J, Zeruto CA, Robin Yabroff K. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1304–12.; Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Vol. 186, Cell. Elsevier B.V.; 2023. p. 1708–28.; Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017;50(1):33.; Sinn HP, Kreipe H. A brief overview of the WHO classification of breast tumors, 4th edition, focusing on issues and updates from the 3rd edition. Breast Care. 2013;8(2):149–54.; Hayes DF, Lippman ME. Breast Cancer. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL, editors. Harrison’s Principles of Internal Medicine, 21e [Internet]. New York, NY: McGraw-Hill Education; 2022. Available from: accessmedicine.mhmedical.com/content.aspx?aid=1198035878; Silva SN, Gomes BC, André S, Félix A, Rodrigues AS, Rueff J. Male and female breast cancer: the two faces of the same genetic susceptibility coin. Breast Cancer Res Treat. 2021 Jul 1;188(1):295–305.; Fondo Colombiano de Enfermedades de Alto Costo C de AC (CAC). Situación del cáncer en la población adulta atendida en el SGSSS de Colombia 2023. Bogotá D.C.; 2024 Sep.; Parsa Y, Mirmalek SA, Kani FE, Aidun A, Salimi-tabatabaee SA, Yadollah-damavandi S, et al. A Review of the Clinical Implications of Breast Cancer Biology. Electron Physician. 2016;8(5):2416–24.; Briceño-Balcázar I, Gómez-Gutiérrez A, Díaz-Dussán NA, Noguera-Santamaría MC, Díaz-Rincón D, Casas-Gómez MC. Mutational spectrum in breast cancer associated BRCA1 and BRCA2 genes in Colombia / Espectro de mutaciones en los genes BRCA1 y BRCA2 asociados a cáncer de mama en Colombia. Colomb Médica VO - 48 [Internet]. 2017;48(2):58. Available from: http://www.bvsspa.es/papi/ezproxy.php?url=http://search.ebscohost.com/login.aspx?direct=true&db=edssci&AN=edssci.S1657.95342017000200058&amp%0Alang=es&site=eds-live&scope=site; Couch, F; DeShano, M; Blackwood, MA; Calzone, K; Stopfer, J; Campeau, L; Ganguly, A; Rebbeck, T; Weber B. BRCA1 Mutations in Women Attending Clinics that Evaluate the Risk of Breast Cancer. N Engl J Med. 1999;336(20):1409–15.; Chafidz A, Kaavessina M, Al-Zahrani S, Al-Otaibi MN. Cancer Staging Manual Seventh Edition. 7th ed. Springer, editor. American Joint Comittee on Cancer. Chicago; 2016. 345–376 p.; Lü Y, Cai MH, Cheng J, Zou K, Xiang Q, Wu JY, et al. A multi-center nested case-control study on hospitalization costs and length of stay due to healthcare-associated infection. Antimicrob Resist Infect Control. 2018;7(1):1–10.; Keats MR, Cui Y, DeClercq V, Grandy SA, Sweeney E, Dummer TJB. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case–control study. Support Care Cancer. 2021;29(2):713–23; Organización Panamericana de la Salud. CIE-10 Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud Volumen 1 Introducción Centros Colaboradores de la OMS para la Clasificación de Enfermedades Informe de la Conferencia Internacional para la Décima Revisi. 2003;(554):1–1158. Available from: http://iris.paho.org/xmlui/bitstream/handle/123456789/6282/Volume1.pdf; Organización Panamericana de la Salud. Clasificación estadística internacional de enfermedades y problemas relacionados con la salud 10a revisión. Washington D.C., E.U.A.; 1995.; Ruíz F, Escobar GM, Milena Cuellar Segura C, Teresa Buitrago Grupo ME, María Henríquez Grupo GM, Stella Ríos Grupo LM, et al. Plan Decenal Salud Pública 2022-2031. Bogotá D.C.; 2022 Apr.; María A, Ligia I-B, Melo-Becerra A, Estefanía D, María P-A, Ramírez-Giraldo T. Evolución y carga financiera de las Enfermedades Crónicas no Transmisibles en Colombia: 2010-2021. 2023.; Colombia. Ministerio de Salud y Protección Social. Oficina de Tecnología de la Información y la Comunicaciones. Lineamiento Técnico para el Registro y envío de los datos del Registro Individual de Prestaciones de Salud – RIPS, desde las Instituciones Prestadoras de Servicios de Salud. Bogotá D.C.; 2019.; Guillen A, Araiza L a, Cerna E, Valenzuela J, Uanl JL, Nicolás S, et al. Métodos No Paramétricos de Uso Común. DAENA Int J Good Conscienc. 2012;7(1):132–55.; Bürkner PC, Doebler P, Holling H. Optimal design of the Wilcoxon–Mann–Whitney-test. Biometrical J. 2017;59(1):25–40.; Neus Canal Díaz. Distribuciones de probabilidad. El teorema central del límite. Rev Seden. 2006;107–20.; Hajian-Tilaki K. Sample size estimation in epidemiologic studies. Casp J Intern Med. 2011;2(4):289–98.; King G, Nielsen R, Coberley C, Pope JE. Comparative Effectiveness of Matching Methods for Causal Inference. Unpubl Manuscr. 2011;15:1–26.; Rosenbaum PR, Rubin DB. The Central Role of the Propensity Score in Observational Studies for Causal Effects Published by : Biometrika Trust Stable URL : http://www.jstor.org/stable/2335942. Biometrika. 1983;70(1):41–55.; Fullerton B, Pöhlmann B, Krohn R, Adams JL, Gerlach FM, Erler A. The Comparison of Matching Methods Using Different Measures of Balance: Benefits and Risks Exemplified within a Study to Evaluate the Effects of German Disease Management Programs on Long-Term Outcomes of Patients with Type 2 Diabetes. Health Serv Res. 2016;51(5):1960–80.; Iacus SM, King G, Porro G. Causal inference without balance checking: Coarsened exact matching. Polit Anal. 2012;20(1):1–24; Iacus SM, King G, Porro G. cem: Software for Coarsened Exact Matching. J Stat Softw [Internet]. 2009;30(9):1–27. Available from: http://www.jstatsoft.org/; Iacus SM, King G, Porro G. Multivariate matching methods that are monotonic imbalance bounding. J Am Stat Assoc. 2011;106(493):345–61.; Sun L, Legood R, Dos-Santos-Silva I, Gaiha SM, Sadique Z. Global treatment costs of breast cancer by stage: A systematic review. PLoS One. 2018;13(11):1–14.; Belger M, Haro JM, Reed C, Happich M, Kahle-Wrobleski K, Argimon JM, et al. How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease - Suggestions from the GERAS observational study. BMC Med Res Methodol [Internet]. 2016;16(1). Available from: http://dx.doi.org/10.1186/s12874-016-0188-1; Azur MJ, Stuart EA, Frangakis C, Leaf PJ. MICE - What is it, and how does it work. Int J Methods Psychiatr. 2012;20(1):40–9.; Graham JW. Missing Data Analysis: Making It Work in the Real World. Annu Rev Psychol. 2008;60(1):549–76.; Medina F, Galván M. Imputación de datos: teoría y práctica [Internet]. Vol. 4, Estudios estadísticos y prospectivos. 2007. 84 p. Available from: http://www.cepal.org/publicaciones/xml/8/14038/lc2024e.pdf; Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ. 2009;339(7713):157–60; Higgins JPT, Green S. Manual Cochrane de revisiones sistemáticas de intervenciones. Cochrane [Internet]. 2011;(March):1–639. Available from: http://www.cochrane.es/?q=es/node/269; Mihaylova B.; Briggs A.; O´Hagan A. and Thompson S. Review of Statistical Methods For Analysing Healthcare Recources And Costs. 2008;1131(2007):1127–31.; Morid MA, Kawamoto K, Ault T, Dorius J, Abdelrahman S. Supervised Learning Methods for Predicting Healthcare Costs: Systematic Literature Review and Empirical Evaluation. AMIA . Annu Symp proceedings AMIA Symp. 2017;2017:1312–21; Botchkarev A. Evaluating Performance of Regression Machine Learning Models Using Multiple Error Metrics in Azure Machine Learning Studio. SSRN Electron J. 2018;1–16.; Guarín A, Ramírez A, Torres F. Modelos Multinomiales : Un análisis de sus propiedades. Rev Ing Medellín. 2012;11(20):87–103.; Hossain MZ. A Review On Some Alternative Specifications Of The Logit Model. J Bus Econ Res. 2011;7(12):15–24.; Fernández PV. SMFR. Regresion Logística Multinomial. CuadSocCienFor. 2004;18:323–7.; Yang C, Delcher C, Shenkman E, Ranka S. Machine learning approaches for predicting high cost high need patient expenditures in health care 08 Information and Computing Sciences 0801 Artificial Intelligence and Image Processing. Biomed Eng Online [Internet]. 2018;17(S1):1–20. Available from: https://doi.org/10.1186/s12938-018-0568-3; Rutten-van Mölken MP, van Doorslaer EK, van Vliet RC. Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Econ. 1994;3(5):333–45.; Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and their determinants in health care: An introductory review. Int J Qual Heal Care. 2011;23(3):331–41.; Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econ. 2001;20(4):461–94; Powers CA, Meyer CM, Roebuck MC, Vaziri B. Predictive modeling of total healthcare costs using pharmacy claims data: A comparison of alternative econometric cost modeling techniques. Med Care. 2005;43(11):1065–72.; Griswold M, Parmigiani G PA and LJ. Analyzing Health Care Costs: A Comparison of Sattistical Methods Motivated by Medicare Colorectal Cancer Charges. Biostatistics. 2004;1(1):1–23.; Center IK. Análisis vecino más cercano [Internet]. 1. Análisis vecino más cercano [Internet]. [cited 2019 Nov 9]. Available from: https://www.ibm.com/support/knowledgecenter/es/SSLVMB_sub/statistics_mainhelp_ddita/spss/base/idh_idd_knn_variables.html. 2019 [cited 2019 Nov 9]. Available from: https://www.ibm.com/support/knowledgecenter/es/SSLVMB_sub/statistics_mainhelp_ddita/spss/base/idh_idd_knn_variables.html; Kumar RR, Viswanath P, Bindu CS. Nearest Neighbor Classifiers : A Review. 2017;13(2):303–11.; Kataria A, Singh MD. International Journal of Emerging Technology and Advanced Engineering A Review of Data Classification Using K-Nearest Neighbour Algorithm. Certif J [Internet]. 2008;9001(6):354–60. Available from: www.ijetae.com; Sushmita S, Newman S, Marquardt J, Ram P, Prasad V, De Cock M, et al. Population cost prediction on public healthcare datasets. ACM Int Conf Proceeding Ser. 2015;2015-May:87–94.; Rucci P, Avaldi VM, Travaglini C, Ugolini C, Berti E, Moro ML, et al. Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree Analysis. PharmacoEconomics - Open [Internet]. 2019;(0123456789). Available from: https://doi.org/10.1007/s41669-019-0166-8; Kang JO, Chung S-H, Suh Y-M. Prediction of Hospital Charges for the Cancer Patients with Data Mining Techniques. J Korean Soc Med Informatics. 2009;15(1):13; Shahid N, Rappon T, Berta W. Applications of artificial neural networks in health care organizational decision-making: A scoping review. PLoS One. 2019;14(2):1–22.; Ministerio de Salud. Resolución 3374 de 2000. 2000;2000(44). 116. Ministerio de Salud y Protección Social. Guía Metodológica Nacional para la Caracterización de Fuentes de Información para la Salud en Colombia. 2014;58. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/GCFI/guia definitiva 19062014.pdf; Oliveira C, Pataky R, Bremner K, Rangrej J, Chan KKW, Cheung WY, et al. Phase-specific and lifetime costs of cancer care in Ontario, Canada. BMC Cancer [Internet]. 2016;16(1):1–12. Available from: http://dx.doi.org/10.1186/s12885-016-2835-7; P MZS. The main methodological issues in costing health care services. A literature review. 2005. Report No.: CHE Research Paper 7.; Instituto de Evaluación Tecnológica en Salud. Manual para la elaboración de evaluaciones económicas en salud. Bogotá D.C.; 2014.; Nacionales D de I y A. ISO 4217 Códigos de Monedas. Bogotá D.C.; 2015.; Kwak SG, Kim JH. Central limit theorem: The cornerstone of modern statistics. Korean J Anesthesiol. 2017;70(2):144–56.; Kim J, Bang H. Three common misuses of P values. Dent Hypotheses. 2016;7(3):73–80.; Jason B. Statistical Methods for Maching Learning. Machine Le. 2019. 64–70; Vapnik V. Statistical Learning Theory. Wiley, editor. New York; 1998. 19–55 p.; O. Jiménez, N. Dussan, L. Sanabria JR. Indicadores de oportunidad reportados por las Entidades Administradoras de Planes de Beneficios a la Superintendencia Nacional de Salud (SNS) durante la vigencia 2012-2013. Seguimiento al cumplimiento del Decreto 019 de 2012. Monit Estratégico. 2014;1(5):55–69.; Ekwueme DU, Allaire BT, Guy GP, Arnold S, Trogdon JG. Treatment Costs of Breast Cancer among Younger Women Aged 19-44 Years Enr1. Ekwueme DU, Allaire BT, Guy GP, Arnold S, Trogdon JG. Treatment Costs of Breast Cancer among Younger Women Aged 19-44 Years Enrolled in Medicaid. Am J Prev Med [Internet]. 2016;50. Am J Prev Med [Internet]. 2016;50(2):278–85. Available from: http://dx.doi.org/10.1016/j.amepre.2015.10.017; Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de Alto Costo. Situación del cáncer en la población adulta atendida en el SGSSS de Colombia 2017. Vol. 91, Situación Del Cancer En Colombia 2017. Bogotá D.C.; 2017.; Díaz Carolina García Magdalena León Felipe Ruiz Francisca Torres Docentes I, Lizama P, Boccardo G. Guía de Asociación entre variables (Pearson y Spearman en SPSS). Santiago de Chile; 2014.; Lahiri B, Agarwal N. Predicting Healthcare Expenditure Increase for an Individual from Medicare Data. 2014;8.; Kotu V, Deshpande B. Model Evaluation. In: Data Science. 2019. p. 263–79.; Martínez Rodríguez M. Errores frecuentes en la interpretación del coeficiente de determinación lineal. Anu jurídico y económico Escur. 2005;(38):315–31.; Bewick V, Cheek L, Ball J. Statistics review 7: Correlation and regression. Crit Care. 2003;7(6):451–9; Kvylseth TO. Cautionary note about r2. Am Stat. 1985;39(4):279–85.; Chai T, Draxler RR. Root mean square error (RMSE) or mean absolute error (MAE)? -Arguments against avoiding RMSE in the literature. Geosci Model Dev. 2014;7(3):1247–50; Piñeros M, Abriata MG, Les M, Bray F. Cancer registration for cancer control in Latin America: a status and progress report. Rev Panam Salud Publica [Internet]. 2017;41. Available from: https://cdn.digital.gob.cl/filer_public/d3/0a/d30a1f5e-53d9-4a31-a4fe-e90d8d9a2348/documento_plan_nacional_de_cancer.pdf; Rummel S, Hueman MT, Costantino N, Shriver CD, Ellsworth RE. Tumour location within the breast: Does tumour site have prognostic ability? Ecancermedicalscience. 2015;9:1–10.; Siotos C, McColl M, Psoter K, Gilmore RC, Sebai ME, Broderick KP, et al. Tumor Site and Breast Cancer Prognosis. Clin Breast Cancer [Internet]. 2018;18(5):e1045–52. Available from: https://doi.org/10.1016/j.clbc.2018.05.007; Fondo Colombiano de Enfermedades de Alto Costo (CAC). La Hipertensión Arterial y la Diabetes Mellitus. Bogotá D.C.; 2023.; Verdial FC, Etzioni R, Duggan C, Anderson BO. Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening. J Surg Oncol. 2017;115(5):517–22.; Haque R, Xu X, Shi J, Kwan ML CR. Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women. Ethn Dis. 2018;28(4):565–74.; Ministerio de Salud y Protección Social-Colciencias. Guia de práctica clínica (GPC) para la detección temprana, tratamiento integral, seguimiento y rehabilitación del cáncer de mama. Bogotá D.C.; 2013 Apr.; Ministerio de salud y Proteccion social, Colciencias. Guía de práctica clínica Hipertensión arterial primaria (hta) 2013-Guía No. 18 [Internet]. 2013. 371 p. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/GPC_Completa_HTA.pdf; República de Colombia M de S y P social. Guía de Práctica Clínica (GPC) para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años. 2015. 606 p.; Medina Orjuela A, Rosero Olarte Ó, Nel Rueda Plata P, Sánchez Escobar F, Chalem Choueka M, González Reyes MÁ, et al. II Consenso Colombiano para el Manejo de la Osteoporosis Posmenopáusica. Rev Colomb Reumatol. 2018;25(3):184–210.; Comisión de Regulación en Salud (CRES). Acuerdo 029 de 2011. Com Regul en Salud [Internet]. 2011;1(03742). Available from: https://www.minsalud.gov.co/salud/pos/mi-plan/Normatividad y estudios de mi plan/Acuerdo 029 pos 2012.pdf; Pardo C, de Vries E. Supervivencia global de pacientes con cáncer en el Instituto Nacional de Cancerología (INC). Rev Colomb Cancerol. 2017;21(1):12–8.; Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Bannon F, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010.; Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337–50.; Yabroff KR, Lund J, Kepka D, Mariotto A. Economic Burden of Cancer in the United States : Estimates , Projections , and Future Research. Cancer Epidemiol Biomarkers Prev. 2011;20 (10) Oc(October):2006–15.; Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States : estimates , projections , and future research. Cancer Epidemiol Biomarkers Prev. 2011;20 (10) Oc:2006–15; McLaughlin SA. Surgical Management of the Breast. Breast Conservation Therapy and Mastectomy. Surg Clin North Am [Internet]. 2013;93(2):411–28. Available from: http://dx.doi.org/10.1016/j.suc.2012.12.006; Harbeck N, Gnant M. Breast cancer. Lancet [Internet]. 2017;389(10074):1134–50. Available from: http://dx.doi.org/10.1016/S0140-6736(16)31891-8; Quiros Enríquez M, Fernández Ruíz DR, Cuevas Pérez OL, Milan vasquez PM, Barrios Romero B, Martínez Barroso T. Revista Electrónica de las Ciencias Médicas en Cienfuegos ISSN:1727-897X Medisur 2012; 10(6). Rev Electrónica las Ciencias Médicas en Cienfuegos. 2012;10(6):495–500.; Tan GH, Bhoo-Pathy N, Taib NA, See MH, Jamaris S, Yip CH. The will rogers phenomenon in the staging of breast cancer - Does it matter? Cancer Epidemiol [Internet]. 2015;39(1):115–7. Available from: http://dx.doi.org/10.1016/j.canep.2014.11.005; Ossa CA, Gómez LR, Ascuntar J, García HI. Supervivencia global y libre de enfermedad según subtipo molecular. RevMédica Sánitas [Internet]. 2015;18(3):122–32. Available from: https://bit.ly/31DSRJM; Velasco Capellas M, Martínez Peralta S, CerdÀ Serdá P, Estival González A, Fernández Bruno M, Lianes Barragan P. Quimioterapia neoadyuvante en el cáncer de mama localmente avanzado. Rev Senol y Patol Mamar. 2012;25(1):14–21.; Murugappan K, Saboo A, Kuo L, Ung O. Paradigm shift in the local treatment of breast cancer: Mastectomy to breast conservation surgery. Gland Surg. 2018;7(6):506–19.; Yabroff KR, Warren JL, Brown ML. Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol. 2007;4(11):643–56.; Ministerio de salud y protección [Internet]. Comisión Nacional de Precios de Medicamentos y Dispositivos Médicos. [Internet]. Bogotá: Listado de medicamentos con precio de referencia, [actualizado agosto de 2018]. 2018. Available from: https://www.minsalud.gov.co/salud/MT/Paginas/listado-de-medicamentos-con-precio-controlado.aspx; Ministerio de salud y protección [Internet]. Comisión Nacional de Precios de Medicamentos y Dispositivos Médicos. 2018; Hussain SA, Williams S, Stevens A, Rea DW. Endocrine therapy for early breast cancer. Expert Rev Anticancer Ther. 2004;4(5):877–88.; Johnston SJ, Cheung K-L. Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation. Oncol Ther [Internet]. 2018;6(2):141–56. Available from: https://doi.org/10.1007/s40487-018-0062-x; Pruthi S, Heisey RE, Bevers TB. Chemoprevention for Breast Cancer. Ann Surg Oncol. 2015;22(10):3230–5; Salkeni M, Hall S. Metastatic breast cancer: Endocrine therapy landscape reshaped. Avicenna J Med. 2017;7(4):144.; Goel S, Sharma R, Hamilton A, Beith J. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Cochrane Database Syst Rev. 2009;(4); Heeke A, Nunes MR, Lynce F. Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer. Curr Breast Cancer Rep. 2018;10(4):241–50.; Riancho JA, Delgado-Calle J. Mecanismos de interacción osteoblasto-osteoclasto. Reumatol Clin. 2011;7(SUPPL.2):1–4.; Ángel J, Mejía A, Guzmán L, Quevedo J, Sánchez R, García O, et al. Mortalidad y recaída en pacientes con cáncer de mama infiltrante sometidas a cirugía conservadora. Rev Colomb Cancerol [Internet]. 2015;19(1):18–28. Available from: http://dx.doi.org/10.1016/j.rccan.2014.09.002; Matsen CB, Neumayer LA. Breast cancer: A review for the general surgeon. JAMA Surg. 2013;148(10):971–9.; Correa J. FJ. CR. MJ. CM. SA, F JD, C R, M J, C M. Principios de cirugía oncológica. Rev Colomb Cirugía. 2016;31(3):185–96.; Piñeiro G, Perelman S, Guerschman JP, Paruelo JM. How to evaluate models: Observed vs. predicted or predicted vs. observed? Ecol Modell. 2008;216(3–4):316–22.; François C. Deep Learning with Python. Manning Publications Co. Shelter Island, NY 11964: Manning Publications Co.; 2018. 56–92 p.; Therneau T, Atkinson B, Ripley B. rpart: Recursive partitioning for classification, regression and survival trees. R package version 4.1-15. 2019; Available from: https://cran.r-project.org/package=rpart; Milborrow AS. Package ‘rpart.plot.’ 2019; Augustovski F, García Martí S, Pichon-Riviere A. Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias: Versión en Español de la Lista de Comprobación CHEERS. Value Heal Reg Issues [Internet]. 2013;2(3):338–41. Available from: http://dx.doi.org/10.1016/j.vhri.2013.10.004; https://repositorio.unal.edu.co/handle/unal/87242; Universidad Nacional de Colombia; Repositorio Institucional Universidad Nacional de Colombia; https://repositorio.unal.edu.co/

الاتاحة: https://repositorio.unal.edu.co/handle/unal/87242
https://repositorio.unal.edu.co/